Inpatient antibiotic resistance: Everyone's problem

Related Experiment Video

Updated: Sep 24, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

Dora E Wiskirchen1,2, Ulysses Wu3,4, Maria Summa1,5

  • 1Department of Pharmacy Practice and Administration, School of Pharmacy, University of Saint Joseph, Hartford, CT, USA.

The Journal of Family Practice
|February 6, 2018
PubMed

Insights

Antimicrobial resistance requires careful antimicrobial use and new drug development. Family physicians can reduce resistance by implementing antimicrobial stewardship in inpatient settings.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Family Medicine

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat.
  • The emergence of multidrug-resistant (MDR) pathogens necessitates urgent action.
  • Appropriate antimicrobial use is crucial for combating AMR.

Purpose of the Study:

  • To outline evidence-based management strategies for inpatient infections caused by resistant bacteria.
  • To highlight the role of family physicians in antimicrobial stewardship.
  • To emphasize methods for reducing the further development of antimicrobial resistance.

Main Methods:

  • Review of current literature on managing resistant bacterial infections in hospitals.
  • Analysis of antimicrobial stewardship principles and practices.
  • Discussion of the family physician's contribution to infection control and AMR reduction.

Main Results:

  • Effective management of inpatient resistant infections relies on judicious antimicrobial selection and duration.
  • Antimicrobial stewardship programs are essential for optimizing patient outcomes and conserving antibiotic effectiveness.
  • Family physicians are integral to implementing stewardship by prescribing appropriately and educating patients.

Conclusions:

  • Coordinated efforts in antimicrobial use and new drug discovery are vital to address AMR.
  • Evidence-based management and robust antimicrobial stewardship are key to controlling resistant infections.
  • Family physicians play a critical role in mitigating the spread of antimicrobial resistance.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...